Beta-adrenergic blocking agents in heart failure
نویسندگان
چکیده
منابع مشابه
Beta-adrenergic blocking agents in heart failure.
Cardiac dysfunction in heart failure is widely recognized as a progressive process, regardless of the clinical signs and symptoms. An increase in cardiac sympathetic drive is one of the earliest neurohormonal responses occurring in patients with heart failure and may be one of the major causes of the progressive remodeling leading to the decline in myocardial function, and responsible for the p...
متن کاملBeta - adrenergic Blocking Agents in Patients with Renal Failure
SIR,-Drs. Priscilla Kincaid-Smith and A. S. P. Hua are disturbed (24 August, p. 520) by our suggestion that beta-adrenergic blocking agents should not be used in patients with moderately severe renal failure (27 April, p. 193). They refer to a previous publication' to show that temporary deterioration in renal function in such patients may occur with the introduction of any hypotensive drug. Th...
متن کاملLetter: Beta-adrenergic blocking agents in patients with renal failure.
SIR,-Drs. Priscilla Kincaid-Smith and A. S. P. Hua are disturbed (24 August, p. 520) by our suggestion that beta-adrenergic blocking agents should not be used in patients with moderately severe renal failure (27 April, p. 193). They refer to a previous publication' to show that temporary deterioration in renal function in such patients may occur with the introduction of any hypotensive drug. Th...
متن کاملHypertension, heart failure, and beta-adrenergic blocking drugs.
eta-adrenergic receptor blocking drugs have arguably preented or delayed more deaths in patients with established eart disease that any other class of pharmaceutical agent 1). These drugs fundamentally alter the clinical course of atients with heart failure and a reduced left ventricular jection fraction, improving left ventricular performance, eversing left ventricular remodeling, and reducing...
متن کاملThe pharmacology of beta-adrenergic blocking agents.
T HE endogenously released neurotransmitter substance, norepinephrine, or an injected sympathomimetic amine, ultimately exerts its actions on an organ system by combining with an area of the effector cell termed the adrenergic “receptor site.” That drugs and neural chemical mediators react with specific receptors in living tissues was suggested by Langley”” in 1905, who suggested that effector ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arquivos Brasileiros de Cardiologia
سال: 2000
ISSN: 0066-782X
DOI: 10.1590/s0066-782x2000001000009